Patterns of National Institutes of Health Grant Funding to Surgical Research and Scholarly Productivity in the United States

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Gail E. Besner
Keyword(s):  
United States ◽  
The United States ◽  
National Institutes Of Health ◽  
Surgical Research ◽  
Scholarly Productivity ◽  
Grant Funding

Patterns of National Institute of Health Grant Funding to Surgical Research and Scholarly Productivity in the United States

2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Jose Wilson Mesquita-Neto ◽  
William Dailey ◽  
Francis I. Macedo ◽  
Nipun B. Merchant
Keyword(s):  
United States ◽  
The United States ◽  
Surgical Research ◽  
Scholarly Productivity ◽  
Grant Funding

Contemporary Trends and End-Results of National Institute of Health Grant Funding to Departments of Urology in the United States: A 10-year Analysis

2021 ◽  
Author(s):  
Nizar Hakam ◽  
Michael Sadighian ◽  
Behnam Nabavizadeh ◽  
Natalie Rios ◽  
Gregory Amend ◽  
...  
Keyword(s):  
United States ◽  
The United States ◽  
Grant Funding ◽  
End Results

Surgical Research Elective in the United States: An Australian Medical Student's Experience

2011 ◽  
Vol 68 (6) ◽  
pp. 562-567 ◽  
Author(s):  
Jeffrey J. Leow ◽  
Sean D. Mackay ◽  
Michael J. Grigg ◽  
Adil H. Haider
Keyword(s):  
United States ◽  
The United States ◽  
Surgical Research

scholarly journals Nanotechnology for the Brain

2014 ◽  
Vol 136 (01) ◽  
pp. 30-35
Author(s):  
Alan S. Brown
Keyword(s):  
United States ◽  
European Union ◽  
Electrical Activity ◽  
Brain Research ◽  
The United States ◽  
Vital Role ◽  
National Institutes Of Health ◽  
Nanowire Arrays ◽  
The European Union ◽  
The Brain

This article explores various nanotechnology-based programs conducted by different teams to study the brain. In the United States, the National Institutes of Health is leading the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, a public–private program that will spend millions on research. The European Union has also proposed a similar effort that will focus on simulating the entire brain on supercomputers. Hongkun Park is developing nanowire arrays that can inject neurons with chemicals or measure electrical activity as it develops in the cell. Weiss and Anne Andrews, a professor of psychiatry at UCLA, have developed sensors that detect the important neurotransmitter, serotonin, by engineering surfaces that bond with it exclusively and not with related molecules. The next step is to create transducers that signal when sensors capture a serotonin molecule. Nanotechnology will play a vital role in that advance.

A Defense of Limited Regulation of Human Genetic Therapies

2018 ◽  
Vol 28 (1) ◽  
pp. 112-120 ◽  
Author(s):  
JAMES J. HUGHES
Keyword(s):  
United States ◽  
Human Subjects ◽  
The United States ◽  
National Institutes Of Health ◽  
Regulatory Agencies ◽  
Cultural Norms ◽  
Regulatory Oversight ◽  
Reproductive Freedom ◽  
Gene Therapies ◽  
Genetic Technologies

Abstract:There is a role for regulatory oversight over new genetic technologies. Research must ensure the rights of human subjects, and all medical products and techniques should be ensured to be safe and effective. In the United States, these forms of regulation are largely the purview of the National Institutes of Health and the Food and Drug Administration. Some have argued, however, that human genetic therapies require new regulatory agencies empowered to enforce cultural norms, protect against hypothetical social harms, or ensure that the human genome remains unchanged. Focusing on the United States, this essay will briefly review these arguments and argue that the current limited regulatory role over human gene therapies is sufficient to protect public health, bodily autonomy, and reproductive freedom.

Sign in / Sign up

Export Citation Format

Share Document